NHS England to fund hepatitis C drug Sovaldi

Hepatitis C patients in the UK are celebrating the news that NHS England has approved an £18.7 million investment to pay for Gilead Science’s controversial treatment Sovaldi.

GPs consider charging for orthotics

South Warwickshire Clinical Commissioning Group (CCG) has drawn criticism for suggesting patients pay for their own crutches, walking sticks and neck braces which are at present free.